COVID Associated Pulmonary Aspergillosis

Author(s):

Shehroz Khan* and Chanchal Maheshwari

Invasive pulmonary aspergillosis is a frequent complication of severe influenza pneumonia with ARDS. However, few of the recent studies have reported correlation and occurrence of aspergillosis in severe COVID-19 cases with pneumonia, referred to as COVID-19 Associated Pulmonary Aspergillosis (CAPA). Pulmonary aspergillosis, an allergic fungal reaction among people who already suffer from chronic lung disorders such as asthma, cystic fibrosis, tuberculosis or emphysema etc. Aspergillosis, a wellknown complication of severe influenza suggests that SARS-CoV-2 might be a risk factor for invasive aspergillosis as COVID leads to the condition of acquired immunodeficiency.